[Significance of a basic therapy of chronic arterial thrombosis with cardiac drugs].
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy* / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D003864:Depression, Chemical; D005121:Extremities / Q000098:blood supply; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000098:blood supply; D010991:Plethysmography; D012039:Regional Blood Flow / Q000187:drug effects*; D013268:Stimulation, Chemical; D013328:Strophanthins / Q000494:pharmacology* / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy*
D013328:Strophanthins
Bedeutung der Basistherapie mit Kardiaka chronischer arterieller Verschlusskrankheiten.